Patients (n = 4,946) | |
---|---|
Age (mean, standard deviation) | 43.9 (15.7) |
> = 55 years (%) | 25.4 |
Sex ratio (male:female) | 1.3 |
WHO regions (%) | |
Africa | 52.9 |
America | 0.7 |
Eastern Europe | 33.8 |
Pacifica | 1.6 |
South East Asia | 11.0 |
Diagnostic: CML (%) | 91.4 |
Initial Phase (%) | |
Chronic | 84.7 |
Accelerated | 13.3 |
Blast crisis | 2.0 |
Status (%) | |
Active | 70.5 |
Closed | 27.5 |
Denied | 2.0 |
Duration of follow up (month; mean, standard deviation) | 25.8 (25.9) |